GLPBio

Metabolism

Research Areas

Products Related to Metabolism(3154)

  • GC79587 structure
    GC795878-Hydroxywarfarin
    CAS: 17834-04-7
    Purity: >98.00%

    8-Hydroxywarfarin (8-OH Warfarin) is a CYP2C9 inhibitor.

  • GC79588 structure
    GC795884'-Hydroxywarfarin
    CAS: 24579-14-4
    Purity: >99.50%

    4′-Hydroxywarfarin is a regioisomeric phenolic derivative of Warfarin.

  • GC79589 structure
    GC79589(R)-Esomeprazole
    CAS: 119141-89-8
    Purity: >96.00%

    (R)-Esomeprazole ((R)-Omeprazole; (+)-Omeprazole) is an orally active cytochrome P450 2C19, CYP3A4, and CYP2C9-related metabolic modulator.

  • GC79590 structure
    GC79590(Rac)-δ-Viniferin
    Purity: >98.50%

    (Rac)-δ-Viniferin is a racemate of δ-Viniferin, an isomer of ε-Viniferin.

  • GC79592 structure
    GC79592(S)-DSM1465
    CAS: 3109381-05-4
    Purity: >99.50%

    (S)-DSM1465 is a Plasmodium dihydroorotate dehydrogenase ( DHODH ) inhibitor.

  • GC79672 structure
    GC79672Pitavastatin magnesium
    CAS: 956116-90-8
    Purity: >99.50%

    Pitavastatin magnesium is an orally active HMG-CoA Reductase inhibitor.

  • GC79675 structure
    GC79675FTO-IN-17
    CAS: 1434867-98-7
    Purity: >98.00%

    FTO-IN-17 is an orally active and brain-penetrant FTO (m 6 A RNA demethylase) inhibitor with an IC 50 of 1.1 μM.

  • GC79677 structure
    GC79677STF-1623
    CAS: 2298391-60-1
    Purity: >99.50%

    STF-1623 is a highly potent, selective, cell-impermeable non-covalent ENPP1 inhibitor, with IC 50 values of 0.6 nM and 800 nM against human ENPP1 and ENPP3, respectively.

  • GC79678 structure
    GC79678LIQ1
    CAS: 2606032-80-6
    Purity: >97.00%

    LIQ1, a flavonoid derivative, is a potent Pyruvate kinase M2 ( PKM2 ) allosteric inhibitor ( IC 50 = 0.39 μM; K d = 4.5 μM) targeting Arg43 within the polyarginine pocket.

  • GC79679 structure
    GC79679Amg-1
    CAS: 496023-55-3
    Purity: >98.00%

    Amg-1 is a potent, reversible and selective indoleamine 2,3-dioxygenase ( IDO1 ) inhibitor ( IC 50 = 3.0 μM).

  • GC79684 structure
    GC79684Azide-PEG2-amide-C14-COOH
    CAS: 3049664-45-8
    Purity: >98.00%

    Azide-PEG2-amide-C14-COOH (Compound LP-379-p) is a lipid-containing compound.

  • GC79685 structure
    GC79685Bis(linoleyl) ketone
    CAS: 1169768-30-2
    Purity: >98.00%

    Bis(linoleyl) ketone is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.

  • GC79686 structure
    GC79686LP-371-p
    CAS: 3049664-89-0
    Purity: >98.00%

    LP-371-p is a lipid that can specifically and efficiently deliver oligonucleotide compounds to the fat tissues in the body (especially fat cells).

  • GC79687 structure
    GC796871-Palmitoyl-2-oleoyl-sn-glycero-3-PS
    CAS: 40290-44-6
    Purity: >99.50%

    2-Oleoyl-1-palmitoyl-sn-glycero-3-phospho-L-serine (16:0-18:1 PS (POPS) free acid) is an anionic phospholipid with oleic acid (18:1) and palmitic acid (16:0) tails containing a carboxylic acid (COOH) and amine (NH2) in their head group.

  • GC79688 structure
    GC79688MeDZ lipid
    Purity: >98.00%

    MeDZ lipid is a zwitterion-type ionizable endosomal membrane destabilizer and anti-inflammatory agent that promotes endosomal escape.

  • GC79689 structure
    GC79689PI(3,5)P2 diC16
    CAS: 214282-36-7
    Purity: >98.00%

    PI(3,5)P2 diC16 is a synthetic inositol phospholipid.

  • GC79690 structure
    GC79690AA76-lipid
    Purity: >99.50%

    AA76-lipid (Compound aa76) is a compound with a C-terminal arginine and histidine.

  • GC79691 structure
    GC79691mPEG2000-DPG
    CAS: 162409-28-1
    Purity: >98.00%

    mPEG2000-DPG is a PEG-based lipid that can be used to formulate lipid nanoparticles for drug delivery.

  • GC79692 structure
    GC79692DSPE-PEG2000-tetrazine
    CAS: 3101670-39-4
    Purity: >98.00%

    DSPE-PEG2000-tetrazine is a synthetic phospholipid modified with PEG2000 and tetrazine moieties.

  • GC79693 structure
    GC79693DSG-PEG2000-OH
    Purity: >95.00%

    DSG-PEG2000-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH).

  • GC79694 structure
    GC79694Lipopeptide CPK4 TFA
    Purity: >98.50%

    Lipopeptide CPK4 TFA is a Cholesterol -modified peptide K4 [(KIAALKE) 3 ]. Lipopeptide CPK4 TFA is capable of coiled-coil formation when attached to liposomes.

  • GC79695 structure
    GC79695Lipopeptide CPE4 TFA
    Purity: >98.50%

    Lipopeptide CPE4 TFA is a PEG-modified peptide E4 [(EIAALEK) 4 ]. Lipopeptide CPE4 TFA is capable of coiled-coil formation when attached to liposomes.

  • GC79696 structure
    GC79696DSPE-PEG3400-MTP
    Purity: >95.00%

    DSPE-PEG3400-MTP is a PEG compound which composed of DSPE and a muscle-targeting peptide (MTP).

  • GC79697 structure
    GC79697DSPE-PEG3400-GNYTCEVTELTREGETIIELK
    Purity: >98.00%

    DSPE-PEG3400-GNYTCEVTELTREGETIIELK is a PEG compound which composed of DSPE and a peptide mimicking the function of CD47 (GNYTCEVTELTREGETIIELK).